ハイファで最高の膵癌医師 - トップ1名の医師

Top pancreatic cancer specialists in Israel include Prof. Joseph Klauzner, Dr. Auala Hubert, and Prof. Ofer Merimsky. These experts hold leadership roles at JCI-accredited centers and focus on complex treatments like the Whipple procedure, HIPEC, and advanced immunotherapy to improve patient results.

• Surgical leadership. Prof. Joseph Klauzner heads surgery at Sourasky and has 45+ years of experience.
• Multidisciplinary care. Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center.
• Advanced research. Prof. Ofer Merimsky has published 300+ peer-reviewed articles and leads oncology at Sourasky.
• Innovative techniques. Dr. Pelles Sharon uses NanoKnife and HIPEC, which is heated chemotherapy for tumors.

Bookimed Expert Insight: Israeli specialists often hold dual certifications in oncology and radiotherapy or specialized surgical oncology. For example, Dr. Auala Hubert is board-certified in both fields. This allows one doctor to manage multiple treatment phases, reducing the time between diagnosis and therapy.

Patient Consensus: Patients value specialists who review imaging results directly and explain if a tumor is operable. They emphasize that starting treatment quickly is vital because time matters when managing pancreatic cancer.

Israeli doctors perform complex Whipple procedures and use NanoKnife IRE technology to treat pancreatic cancer. Specialists like Joseph Klauzner at Sourasky Medical Center (Ichilov) also offer HIPEC and minimally invasive surgeries. These methods aim to remove tumors while sparing healthy tissue and reducing recovery times.

• Whipple procedure. Joseph Klauzner at Sourasky performs this complex surgery to remove pancreatic head tumors.
• NanoKnife IRE. This technology uses electrical pulses to destroy tumors near vital blood vessels safely.
• HIPEC treatment. Dr. Pelles Sharon uses heated chemotherapy directly in the abdomen during surgery.
• Distal pancreatectomy. Surgeons remove tumors from the pancreatic tail, often using minimally invasive techniques.

Bookimed Expert Insight: Israeli surgical teams often include oncology researchers like Prof. Nadir Arber at Sourasky Medical Center. This integration means surgeons can use molecular research to decide which patients benefit most from surgery. Many top specialists have over 40 years of experience, which is vital for complex procedures like the Whipple.

Patient Consensus: Patients are often relieved that surgeons can operate on tumors previously labeled as inoperable. They appreciate how doctors explain the surgery steps clearly, which helps them feel much less anxious. Many notice that the focused care in specialized gastrointestinal units helps them start walking sooner after surgery.

Doctors in Israel treat pancreatic cancer through multidisciplinary teams, combining robot-assisted surgery with specialized oncology protocols. Experts like Dr. Pelles Sharon and Dr. Ron Greenberg at Sourasky Medical Center (Ichilov) perform complex Whipple procedures using minimally invasive techniques to improve recovery. This approach integrates early genetic profiling and targeted therapies for precise tumor management.

• Surgical precision. Specialists perform complex procedures like the Whipple surgery using robotic systems for better accuracy.
• Targeted radiation. Clinics provide advanced options like NanoKnife and stereotactic radiosurgery for treating inoperable pancreatic tumors.
• Early diagnosis. Professors like Dr. Nadir Arber focus on prevention and early detection of gastrointestinal cancers.
• Personalized oncology. Specialists use genomic markers to select immunotherapy or intensive chemotherapy protocols for each patient.

Bookimed Expert Insight: Israeli oncology centers demonstrate a strong focus on surgical innovation, where many specialists hold dual expertise. For example, Dr. Auala Hubert at Hadassah Medical Center is board-certified in both medical oncology and radiotherapy. This allows a single expert to manage multiple treatment modalities, ensuring more seamless coordination and faster transitions between radiation and chemotherapy for patients.

Patient Consensus: Patients are often surprised by the intensive approach that prioritizes surgery even in advanced cases. They frequently note how quickly the transition happens from a PET/CT or biopsy to an active treatment plan.